Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postoperative Opt-In Narcotics Treatment in Breast

NCT05078398 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT05078398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05078398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postoperative Opt-In Narcotics Treatment in Breast
Lead sponsor
University of California, Los Angeles
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2022
Completion date
January 1, 2025
Enrollment
109 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast surgery, opioid use